Ian Fingerman, Ph.D.
Dr. Ian Fingerman leads the branch in supporting and directing research defining the genetic and epigenetic mechanisms of tumorigenesis and mechanisms of chemical and physical carcinogenesis. He manages a portfolio of grants focusing on genetic variation in cancer and noncoding RNAs (e.g., miRNAs), as well as applications with large scale, whole "omics" approaches.
Dr. Fingerman enjoys staying up-to-date on the latest basic science research and engaging the public through scientific outreach.
In addition to his work for DCB, Dr. Fingerman is a member of the Data Management and Sharing Working Group - “Genomics and other Omics."
Research Programs
Dr. Fingerman is also involved in NIH Common Fund programs:
Background
Before coming to DCB, he worked as a project lead on a database for epigenetic and epigenomic data sets at the National Center for Biotechnology Information (NCBI).
Education
- Ph.D., Molecular Biochemistry, Rutgers University